Fuan Pharmaceutical Group Co Cash Flow Reinvestment Rate
Fuan Pharmaceutical Group Co cash flow reinvestment rate. Fuan Pharmaceutical Group Co (300194) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥22.81 Million (capex CN¥22.81 Million ) from operating cash flow of CN¥100.27 Million. Explore 300194 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Fuan Pharmaceutical Group Co (2007–2025)
Cash flow reinvestment rate of Fuan Pharmaceutical Group Co from 2007 to 2025. Historical reinvestment intensity for Fuan Pharmaceutical Group Co across 18 annual periods. Explore Fuan Pharmaceutical Group Co capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Fuan Pharmaceutical Group Co Cash Flow Reinvestment Rate by Year (2007–2025)
Fuan Pharmaceutical Group Co cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Fuan Pharmaceutical Group Co. For the full cash flow conversion analysis, see how efficiently does Fuan Pharmaceutical Group Co generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | CN¥204.53 Million | CN¥312.32 Million | CN¥108.43 Million | ▼ -23.3% |
| 2024 | 0.85x | CN¥259.26 Million | CN¥303.59 Million | CN¥241.79 Million | ▼ -9.2% |
| 2023 | 0.94x | CN¥309.30 Million | CN¥328.98 Million | CN¥215.68 Million | ▼ -61.2% |
| 2022 | 2.42x | CN¥823.11 Million | CN¥339.50 Million | CN¥383.10 Million | ▲ +42.3% |
| 2021 | 1.70x | CN¥438.18 Million | CN¥257.13 Million | CN¥413.03 Million | ▼ -30.2% |
| 2020 | 2.44x | CN¥396.76 Million | CN¥162.55 Million | CN¥344.53 Million | ▲ +171.9% |
| 2019 | 0.90x | CN¥265.34 Million | CN¥295.63 Million | CN¥223.80 Million | ▼ -5.1% |
| 2018 | 0.95x | CN¥253.16 Million | CN¥267.68 Million | CN¥132.16 Million | ▲ +71.1% |
| 2017 | 0.55x | CN¥250.62 Million | CN¥453.37 Million | CN¥84.62 Million | ▼ -80.2% |
| 2016 | 2.79x | CN¥1.04 Billion | CN¥374.16 Million | CN¥153.91 Million | ▼ -4.0% |
| 2015 | 2.91x | CN¥468.58 Million | CN¥161.03 Million | CN¥92.16 Million | ▲ +51.6% |
| 2013 | 1.92x | CN¥171.97 Million | CN¥89.61 Million | CN¥171.97 Million | ▼ -9.1% |
| 2012 | 2.11x | CN¥132.44 Million | CN¥62.77 Million | CN¥132.44 Million | ▲ +35.6% |
| 2011 | 1.56x | CN¥100.92 Million | CN¥64.85 Million | CN¥100.92 Million | ▲ +139.4% |
| 2010 | 0.65x | CN¥68.74 Million | CN¥105.74 Million | CN¥68.74 Million | ▲ +31.4% |
| 2009 | 0.49x | CN¥31.04 Million | CN¥62.75 Million | CN¥31.04 Million | ▼ -29.4% |
| 2008 | 0.70x | CN¥34.48 Million | CN¥49.23 Million | CN¥34.48 Million | ▼ -9.1% |
| 2007 | 0.77x | CN¥14.58 Million | CN¥18.92 Million | CN¥14.58 Million | — |